GOLD 2027 assessment framework

COPD GOLD Classification Calculator

Calculate the GOLD 1–4 airflow obstruction grade and A/B/E group from post-bronchodilator spirometry, symptoms, and exacerbations over the past year.

For adults with clinician-confirmed COPD. Values are processed in your browser, without patient identifiers.

Enter the COPD assessment

Use adult post-bronchodilator spirometry and a completed symptom assessment. Interpret results in clinician-confirmed COPD.

1. Post-bronchodilator spirometry

Enter a ratio such as 0.60, rather than 60%.

Use percent predicted from the report. Values may exceed 100%.

2. Symptom assessment

Enter the completed questionnaire’s total. CAT and CAAT scores are interchangeable.

3. Moderate or severe exacerbations in the past 12 months

Use clinically assessed events from the record, including events treated with systemic steroids and/or antibiotics or requiring hospital care. Mild symptom fluctuations alone do not count.

GOLD 2027 places one moderate or severe event in group E.

GOLD classification result

2027 framework

Enter the assessment to see the GOLD airflow grade and A/B/E group, with the reasoning for each.

Based on the GOLD 2027 assessment framework. Input values are not rounded before classification. Treatment decisions require a complete clinical review, including current therapy and response.

GOLD COPD stages 1–4 by FEV₁

Often called COPD stages, these grades describe the degree of airflow obstruction. Apply them to post-bronchodilator FEV₁ percent predicted when the ratio is below 0.70 and COPD has been clinically established. GOLD assessment table

GOLD grades of airflow obstruction based on post-bronchodilator FEV₁ percent predicted
GradeAirflow obstructionFEV₁ (% predicted)
GOLD 1MildFEV₁ ≥80% predicted
GOLD 2Moderate50% ≤ FEV₁ <80% predicted
GOLD 3Severe30% ≤ FEV₁ <50% predicted
GOLD 4Very severeFEV₁ <30% predicted

Percent predicted = measured FEV₁ ÷ predicted FEV₁ × 100. Use the reference values on the report or review the GLI spirometry calculator.

GOLD A, B, and E classification

ABE grouping adds symptom burden and recent exacerbation history. It is assessed separately from the airflow grade. GOLD 2027 ABE criteria

Group A

No moderate or severe events in the past year, with CAT/CAAT <10 or mMRC 0–1.

Group B

No moderate or severe events in the past year, with CAT/CAAT ≥10 or mMRC ≥2.

Group E

At least one moderate or severe event in the past year, at any symptom level.

Classification example

With a post-bronchodilator ratio of 0.55, FEV₁ of 55% predicted, CAT/CAAT of 12, and no moderate or severe events, the result is GOLD 2 and group B. One moderate exacerbation changes the group to E, while the airflow grade remains 2.

COPD GOLD classification questions

Why does one exacerbation lead to group E?

The one-event threshold was introduced in GOLD 2026 and retained in 2027. A single moderate or severe exacerbation qualifies for group E. Older 2025 summaries used a different threshold, which can produce a different group. 2026 framework · 2027 framework

Should I use CAT, CAAT, or mMRC?

CAT has been renamed CAAT, with interchangeable scores. It measures broader health impact, while mMRC focuses on breathlessness. Select the completed assessment available in the record. If different instruments disagree, review the full symptom assessment rather than averaging their scores. GOLD symptom assessment

What if FEV₁/FVC is 0.70 or higher?

This tool withholds a COPD classification. A preserved ratio can coexist with symptoms or impaired lung function that warrant assessment. GOLD recommends repeat testing when confirming obstruction around the threshold, including ratios between 0.60 and 0.80. Spirometric diagnostic context

Does the grade determine treatment or life expectancy?

A classification summarizes selected assessment findings. Current treatment, response, comorbidities, exacerbation details, patient goals, and other clinical factors guide management. The BODE index calculator adds functional information, with its own prognostic limitations.

Clinical references and version

Implements GOLD 2027 classification criteria. Sources checked November 17, 2026. PulmTools provides an independent educational implementation.